BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2317836)

  • 1. Specific expression of proteins and phosphoproteins in 3T3 T mesenchymal stem cells at distinct growth arrest and differentiation states.
    Sparks RL; Zschunke MA; Seibel-Ross EI; Tracy R; Zalitis JG; Boman BM; Hoerl BJ; Scott RE
    Cell Tissue Kinet; 1990 Mar; 23(2):71-87. PubMed ID: 2317836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated control of proliferation and differentiation of mesenchymal stem cells.
    Filipak M; Estervig DN; Tzen CY; Minoo P; Hoerl BJ; Maercklein PB; Zschunke MA; Edens M; Scott RE
    Environ Health Perspect; 1989 Mar; 80():117-25. PubMed ID: 2647473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological mechanisms for the loss of the differentiated phenotype by non-terminally differentiated adipocytes.
    Hoerl BJ; Wier ML; Scott RE
    Exp Cell Res; 1984 Dec; 155(2):422-34. PubMed ID: 6209152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth arrest of proadipocytes at a distinct predifferentiation G1 state associated with cytotoxic responsiveness to 8-bromo cyclic AMP.
    Florine DL; Hoerl BJ; Scott RE
    Cell Differ; 1982 Jun; 11(4):195-202. PubMed ID: 6288270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topography of the predifferentiation GD growth arrest state relative to other growth arrest states in the G1 phase of the cell cycle.
    Wille JJ; Scott RE
    J Cell Physiol; 1982 Jul; 112(1):115-22. PubMed ID: 7107711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential mitogenic effects of methyl isobutyl xanthine and a tumor growth factor on G1-arrested 3T3 T proadipocytes at the predifferentiation GD state and the growth-factor deficiency GS state.
    Scott RE; Yun K; Florine DL
    Exp Cell Res; 1983 Feb; 143(2):405-14. PubMed ID: 6187588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell surface characteristics of proadipocytes growth arrested at the predifferentiation GD state. Defects associated with neoplastic transformation.
    Boman BM; Maercklein PB; Hoerl BJ; Scott RE
    Lab Invest; 1983 Feb; 48(2):199-204. PubMed ID: 6823097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coupling of growth arrest and differentiation at a distinct state in the G1 phase of the cell cycle: GD.
    Scott RE; Florine DL; Wille JJ; Yun K
    Proc Natl Acad Sci U S A; 1982 Feb; 79(3):845-9. PubMed ID: 6174983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coupling of proadipocyte growth arrest and differentiation. II. A cell cycle model for the physiological control of cell proliferation.
    Scott RE; Hoerl BJ; Wille JJ; Florine DL; Krawisz BR; Yun K
    J Cell Biol; 1982 Aug; 94(2):400-5. PubMed ID: 6809770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonterminally differentiated cells express decreased growth factor responsiveness.
    Hoerl BJ; Scott RE
    J Cell Physiol; 1989 Apr; 139(1):68-75. PubMed ID: 2708458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of distinct steps in the adipocyte differentiation pathway in 3T3 T mesenchymal stem cells by dimethyl sulphoxide (DMSO).
    Wang H; Scott RE
    Cell Prolif; 1993 Jan; 26(1):55-66. PubMed ID: 8439589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of two 36-kD phosphoproteins associated with altered differentiation in retrovirus-transformed Balb/MK-2 mouse keratinocytes.
    Makino JK; Weissman BE
    Pathobiology; 1991; 59(6):384-90. PubMed ID: 1930691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consecutive silver staining and autoradiography of 35S and 32P-labeled cellular proteins: application for the analysis of signal transducing pathways.
    Luo LD; Wirth PJ
    Electrophoresis; 1993; 14(1-2):127-36. PubMed ID: 8462506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polypeptide changes associated with loss of proliferative potential during the terminal event in differentiation.
    Wier ML; Scott RE
    J Cell Biochem; 1987 Feb; 33(2):137-50. PubMed ID: 2437134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation, dedifferentiation, and transdifferentiation of BALB/c 3T3 T mesenchymal stem cells: potential significance in metaplasia and neoplasia.
    Sparks RL; Seibel-Ross EI; Wier ML; Scott RE
    Cancer Res; 1986 Oct; 46(10):5312-9. PubMed ID: 3756880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aproliferin--a human plasma protein that induces the irreversible loss of proliferative potential associated with terminal differentiation.
    Wier ML; Scott RE
    Am J Pathol; 1986 Dec; 125(3):546-54. PubMed ID: 3799819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoplastic transformation and defective control of cell proliferation and differentiation.
    Wille JJ; Maercklein PB; Scott RE
    Cancer Res; 1982 Dec; 42(12):5139-46. PubMed ID: 6291749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A recombinant human TGF-beta1 fusion protein with collagen-binding domain promotes migration, growth, and differentiation of bone marrow mesenchymal cells.
    Andrades JA; Han B; Becerra J; Sorgente N; Hall FL; Nimni ME
    Exp Cell Res; 1999 Aug; 250(2):485-98. PubMed ID: 10413602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel, stage-specific polypeptides associated with the differentiation of mammary epithelial stem cells to alveolar-like cells in culture.
    Paterson FC; Rudland PS
    J Cell Physiol; 1985 Sep; 124(3):525-38. PubMed ID: 3900100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mad1 expression in the absence of differentiation: effect of cAMP on the B-lymphoid cell line Reh.
    Naderi S; Blomhoff HK
    J Cell Physiol; 1999 Jan; 178(1):76-84. PubMed ID: 9886493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.